ICD10 code of Angelman Syndrome and ICD9 code

Angelman Syndrome is classified under ICD-10 code Q93.59 (Other deletions of part of a chromosome) and was previously identified under ICD-9 code 758.39 (Other disorders of autosomal origin). These diagnostic codes are essential for medical billing, insurance authorization, and tracking the clinical management of individuals living with this neurogenetic condition.

What exactly is Angelman Syndrome?

Angelman Syndrome is a complex neurogenetic disorder primarily characterized by severe developmental delay, speech impairment, movement or balance disorders, and a uniquely happy demeanor. The condition is caused by the loss of function of the UBE3A gene on the maternally inherited chromosome 15. Because Angelman Syndrome affects approximately 1 in 12,000 to 20,000 people worldwide, it is classified as a rare disease. Within the DiseaseMaps.org community, 263 people with Angelman Syndrome have connected to share their experiences, providing a vital network for families navigating this diagnosis.

How is Angelman Syndrome diagnosed and coded?

Diagnosis of Angelman Syndrome typically begins with clinical observation of developmental milestones and characteristic physical features. Confirmatory testing involves genetic analysis, such as chromosomal microarray or methylation studies, to identify the specific molecular mechanism—such as maternal deletion, paternal uniparental disomy, or an imprinting defect. Once a clinical diagnosis is confirmed, physicians use the ICD-10 code Q93.59 to document Angelman Syndrome in electronic health records. While the ICD-9 code 758.39 is no longer used for current clinical billing, it may still appear in older medical records or historical research documentation.

What are the primary clinical features of Angelman Syndrome?

The clinical presentation of Angelman Syndrome is distinct and often becomes more apparent between 6 and 12 months of age. While every individual is unique, the following clinical features are commonly observed by specialists:

• Severe developmental delay and significant speech impairment (often limited to a few words or none).


• Movement or balance disorders, typically including ataxia of gait and/or tremulous movement of limbs.


• A behavioral uniqueness characterized by frequent laughter, smiling, and an excitable personality.


• High prevalence of epilepsy, with seizures often beginning before the age of 3 years.


• Microcephaly (smaller than average head size) that is usually present by age 2.


• Specific sleep disturbances and a fascination with water or crinkly objects.

Is there a cure for Angelman Syndrome?

Currently, there is no curative treatment for Angelman Syndrome; however, medical management is highly effective at improving quality of life. Treatment is multidisciplinary and focuses on addressing specific symptoms, such as anti-seizure medications for epilepsy, physical therapy to improve motor skills, and speech therapy or the use of augmentative and alternative communication (AAC) devices. Medical researchers are actively investigating gene therapy and targeted molecular treatments, offering hope for future therapeutic advancements in the management of Angelman Syndrome.

Next steps

• Consult with a clinical geneticist to confirm the specific molecular subtype of the condition.


• Establish a care team including a neurologist, physical therapist, and speech-language pathologist.


• Connect with the 263 members on DiseaseMaps.org to share resources and emotional support.


• Review current clinical trials on ClinicalTrials.gov to stay informed about potential emerging therapies.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Angelman Syndrome.


• Orphanet: Rare Disease Database (ORPHA: 85).


• Online Mendelian Inheritance in Man (OMIM): #105830 (Angelman Syndrome).


• Angelman Syndrome Foundation: Clinical Guidelines and Research Updates.